MD - Pediatrix Medical Group, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $23.20 DETAILS

Stock News

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

May 21, 2026 06:46 AM • zacks.com

Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced the appointment of Angel S. Angelov, MD, MBA, as Chief Medical Officer (CMO), effective May 18, 2026. "We are pleased to welcome Dr. Angelov to the Vistagen team,” said President and Chief Executive Officer of Vista.

May 19, 2026 04:30 AM • businesswire.com

Passkey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination Platform

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics, the architect of the Locksmith® platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today announced the appointment of Mandeep Kaur, MD, MS, as Chief Medical Officer. Dr. Kaur will lead Passkey's clinical and medical strategy as it advances a series of Locksmith-identified drug combinations into clinical studies across multiple therapeutic areas. Dr. Kaur most recently served as Senior.

May 19, 2026 04:00 AM • businesswire.com

Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.

May 15, 2026 08:57 AM • zacks.com

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

May 14, 2026 06:51 AM • zacks.com

Pediatrix Medical Group Q1 Earnings Call Highlights

Pediatrix Medical Group NYSE: MD reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported by higher pricing, improved collections and continued strength in payer mix despite modest volume declines across its service lines.

May 11, 2026 11:09 AM • marketbeat.com

Pediatrix Medical Q1 Earnings Beat Estimates on Same-Unit Strength

Pediatrix Medical Group tops Q1 estimates as stronger reimbursements and same-unit gains lift results despite lower patient volumes.

May 05, 2026 12:00 PM • zacks.com

Pediatrix Medical Group, Inc. (MD) Q1 2026 Earnings Call Transcript

May 05, 2026 07:31 AM • seekingalpha.com

Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.33 per share a year ago.

May 05, 2026 04:27 AM • zacks.com

Pediatrix Medical Group Reports First Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.

May 05, 2026 02:00 AM • businesswire.com

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon (OGN) came out with quarterly earnings of $0.71 per share, missing the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.02 per share a year ago.

Apr 30, 2026 06:30 AM • zacks.com

Ambience Healthcare Appoints Michael Han, MD, MBA as Chief Medical Officer

SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading AI platform for clinical documentation and revenue integrity, today announced the appointment of Michael Han, MD, MBA as Chief Medical Officer (CMO). In this role, Dr. Han will lead Ambience's clinical strategy as the company continues to expand beyond ambient documentation into a broader system of intelligence designed to help health systems apply AI to rethink clinical workflow, revenue integrity, and operational performance at.

Apr 23, 2026 05:05 AM • businesswire.com

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Apr 21, 2026 06:46 AM • zacks.com

Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026.

Apr 20, 2026 02:45 AM • businesswire.com

Ritholtz Wealth Management Invests $2.16 Million in Pediatrix Medical Group, Inc. $MD

Ritholtz Wealth Management acquired a new position in Pediatrix Medical Group, Inc. (NYSE: MD) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 101,115 shares of the company's stock, valued at approximately $2,163,000. Ritholtz Wealth Management owned about 0.12% of

Apr 13, 2026 01:40 AM • defenseworld.net

SG Americas Securities LLC Has $1.56 Million Position in Pediatrix Medical Group, Inc. $MD

SG Americas Securities LLC reduced its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 41.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,060 shares of the company's stock after selling 51,082 shares during the period. SG

Apr 07, 2026 01:05 AM • defenseworld.net

Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $19.80

Pediatrix Medical Group, Inc. (NYSE: MD - Get Free Report) has earned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the

Apr 05, 2026 09:09 PM • defenseworld.net

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Apr 02, 2026 06:51 AM • zacks.com

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Apr 01, 2026 06:46 AM • zacks.com

Reviewing IceCure Medical (NASDAQ:ICCM) and Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE: MD - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, dividends, valuation and profitability. Risk and Volatility Pediatrix Medical Group

Mar 28, 2026 10:13 PM • defenseworld.net